Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

NCT06224192

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kern Research Inc Bakersfield, California, United States
  • Long Beach Research Institute Long Beach, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Havana Research Institute Inc Pasadena, California, United States
View all 47 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

NCT06181435

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Eclipse Clinical Research- Site Number : 8401158 Tucson, Arizona, United States
  • Torrance Clinical Research- Site Number : 8401027 Lomita, California, United States
  • Dermatology Research Associates - Los Angeles- Site Number : 8401092 Los Angeles, California, United States
View all 142 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

NCT06700499

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing Luhe Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Xiyuan Hospital of CACMS Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
View all 50 locations
View Trial Details
Completed

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

NCT06345404

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Site 5 Birmingham, Alabama, United States
  • Clinical Site 9 Tucson, Arizona, United States
  • Clinical Site 3 North Little Rock, Arkansas, United States
  • Clinical Site 2 Fremont, California, United States
View all 16 locations
View Trial Details
Completed

Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06585202

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Aclaris Investigational Site Birmingham, Alabama, United States
  • Aclaris Investigational Site Encino, California, United States
  • Aclaris Investigational Site San Diego, California, United States
  • Aclaris Investigational Site Plainfield, Indiana, United States
View Trial Details
Completed

A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

NCT05372419

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
  • Axon Clinical Research Inglewood, California, United States
View all 36 locations
View Trial Details

Related conditions